Loading
A phase 2 trial of High-dose intravenous vitamin C in Rectal cancer, run by Zhou Fuxiang, with a status the registry has not verified recently.
Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer is a phase 2 interventional study registered as NCT04801511 by Zhou Fuxiang, with 60 participants planned, started 2021-03-08 and due to reach its primary completion in 2023-06-30. Interventions recorded: Vitamin C. Conditions recorded: Rectal Cancer.
Linked to the technology High-dose intravenous vitamin C because the registry's title names it ("high dose intravenous vitamin c") and Rectal cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares High-dose intravenous vitamin C, Rectal cancer and the tag pipeline.
Shares High-dose intravenous vitamin C and the tag pipeline.
Shares Rectal cancer and the tag pipeline.
Shares Rectal cancer and the tag pipeline.
Shares Rectal cancer and the tag pipeline.
Shares Rectal cancer and the tag pipeline.
Shares Rectal cancer and the tag pipeline.
Shares Rectal cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/